期刊文献+

间充质干细胞与复发性流产 被引量:2

原文传递
导出
摘要 复发性流产(RSA)的发生率为1%~5%,其病因复杂多样,且到目前为止仍有部分原因不明,导致治疗效果不佳,给女性带来生理及心理上的严重伤害[1]。阐明RSA的病因,探索精准治疗已成为该疾病迫切需要解决的问题,间充质干细胞(MSCs)为临床很多疾病的治疗提供了新思路、新方向并取得了令人可喜的研究成就,这其中就包括RSA与MSCs的相关研究。本文就目前MSS在KSA发生及治疗中的研究进展做一综述,以期为RSA的发病机制及治疗研究提供新方向,也为MSCs在RSA临床中的应用提供理论基础。
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2019年第4期478-481,共4页 Chinese Journal of Practical Gynecology and Obstetrics
基金 南通市市级科技计划指令性项目 江苏省重点研发计划(社会发展)项目面上项目(BE2018672) 江苏省博士后面上项目(2018K046A) 第64批中国博士后科学基金面上项目 国家自然科学基金青年基金(81401272)
关键词 复发性流产 间充质干细胞 发病机制 治疗 recurrent spontaneous abortion mesenchymal stem cells pathogenesis therapy
  • 相关文献

参考文献6

二级参考文献30

  • 1Andreoli L, Nalli C, Borghi MO, et al. Domain 1 is the main specificity of anti-beta2 glycoprotein I antibodies in systemic autoimmune diseases [J]. Arthritis Rheum, 2013,65(10):$4.
  • 2Carp HJA, Meroni PL, Shoenfeld Y. Autoantibodies as predic- tors of pregnancy complications[J]. Rheumatology, 2008,47:6-8.
  • 30stensen M, Brucato A, Carp H, et al. Pregnancy and reproduc- tion in autoimmune rheumatic diseases [J3. Rheumatology,2011, 50:657-664.
  • 4Bates SM. VTE, thrombophilia, antithrombotic therapy, and preg- nancy. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians, Evidence-Based Clinical Practice Guidelines [ J ]. C hest,2012,141 (Suppl.) : e691 S- e736S.
  • 5van Hoorn ME,Hague WM,van Pampus MG, et al. Low-molecu- lar- weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphosphotipid anti- bodies: the FRUIT-RCT[J]. Eur J Obstet Gynecol Reprod Bin|, 2016,197:168-173.
  • 6Bramham K,Hunt BJ,Germainetal S.Pregnancy outcome in differ- ent clinical phenotypes of antiphospholipid syndrome [J]. Lu- pus, 2010, 19(1):58-64.
  • 7Alijotas-Reig J.Treatment of refractory obstetric antiphos- pho- lipid syndrome: the state of the art and new trends in the thera- peutic management[J]. Lupus, 2013, 22, (1): 6-17.
  • 8Bramham K, Hunt BJ, Germain Set al. Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome [J]. Lupus, 2010, 19:58-64.
  • 9Mar N, Kosowicz R, Hook K. Recurrent thrombosis prevention with intravenous immunogIobulin and hydroxychloroquine dur- ing pregnancy in a patient with history of catastrophic antiphos- pholipid syndrome and pregnancy loss [J]. J Thromb Thromboly- sis, 2014, 38:196-200.
  • 10Tenti S, Chelescbi S, GuideUi GM, et al. Intravenous immuno- globulins and antiphospholipid syndrome: how, when and why? A review of the literature[J].Autoimmun Rev, 2016,15:22-235.

共引文献102

同被引文献19

引证文献2

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部